RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Shanna Burke to Apolipoprotein E4

This is a "connection" page, showing publications Shanna Burke has written about Apolipoprotein E4.
Connection Strength

3.011
  1. Burke SL, Hu T, Spadola CE, Li T, Naseh M, Burgess A, Cadet T. Mild cognitive impairment: associations with sleep disturbance, apolipoprotein e4, and sleep medications. Sleep Med. 2018 12; 52:168-176.
    View in: PubMed
    Score: 0.655
  2. Burke SL, Hu T, Spadola CE, Burgess A, Li T, Cadet T. Treatment of Sleep Disturbance May Reduce the Risk of Future Probable Alzheimer's Disease. J Aging Health. 2019 02; 31(2):322-342.
    View in: PubMed
    Score: 0.653
  3. Burke SL, Maramaldi P, Cadet T, Kukull W. Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry. 2018 Jan; 33(1):200-211.
    View in: PubMed
    Score: 0.598
  4. Burke SL, Maramaldi P, Cadet T, Kukull W. Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development. Arch Gerontol Geriatr. 2016 Jul-Aug; 65:231-8.
    View in: PubMed
    Score: 0.553
  5. Burke SL, Maramaldi P, Cadet T, Kukull W. Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia. Int Psychogeriatr. 2016 09; 28(9):1409-24.
    View in: PubMed
    Score: 0.552
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support